Abstract:Background: Use of organophosphate flame retardants (OPFRs) including tris(1,3-dichloro-2-propyl) phosphate, triphenyl phosphate, tris(1-chloro-2-propyl) phosphate, and tris-2-chloroethyl phosphate, in consumer products is on the rise because of the recent phase out of polybrominated diphenyl ether (PBDE) flame retardants. Some of these chemicals are also used as plasticizers or lubricants in many consumer products. Objectives: To assess human exposure to these chlorinated and non-chlorinated organophosphates, and non-PBDE brominated chemicals in a representative sample of the U.S. general population 6years and older from the 2013-2014 National Health and Nutrition Examination Survey (NHANES). Methods: We used solid-phase extraction coupled to isotope dilution high-performance liquid chromatography-tandem mass spectrometry after enzymatic hydrolysis of conjugates to analyze 2666 NHANES urine samples for nine biomarkers: diphenyl phosphate (DPHP), bis(1,3-dichloro-2-propyl) phosphate (BDCIPP), bis-(1-chloro-2-propyl) phosphate (BCIPP), bis-2-chloroethyl phosphate (BCEP), di-n-butyl phosphate (DNBP), di-p-cresylphosphate (DpCP), di-o-cresylphosphate (DoCP), dibenzyl phosphate (DBzP), and 2,3,4,5-tetrabromobenzoic acid (TBBA). We calculated the geometric mean (GM) and distribution percentiles for the urinary concentrations (both in micrograms per liter [μg/L] and in micrograms per gram of creatinine). We only calculated GMs for analytes with an overall weighted frequency of detection >60%. For those analytes, we also a) determined weighted Pearson correlations among the log10-transformed concentrations, and b) used regression models to evaluate associations of various demographic parameters with urinary concentrations of these biomarkers. Results: We detected BDCIPP and DPHP in approximately 92% of study participants, BCEP in 89%, DNBP in 81%, and BCIPP in 61%. By contrast, we detected the other biomarkers much less frequently: DpCP (13%), DoCP (0.1%), TBBA (5%), and did not detect DBzP in any of the participants. Concentration ranges were highest for DPHP (<0.16-193μg/L), BDCIPP (<0.11-169μg/L), and BCEP (<0.08-110μg/L). Regardless of race/ethnicity, 6-11year old children had significantly higher BCEP adjusted GMs than other age groups. Females had significantly higher DPHP and BDCIPP adjusted GM than males, and were more likely than males to have DPHP concentrations above the 95th percentile (odds ratio=3.61; 95% confidence interval, 2.01-6.48). Conclusions: Our results confirm findings from previous studies suggesting human exposure to OPFRs, and demonstrate, for the first time, widespread exposure to several OPFRs among a representative sample of the U.S. general population 6years of age and older. The observed differences in concentrations of certain OPFRs biomarkers by race/ethnicity, in children compared to other age groups, and in females compared to males may reflect differences in lifestyle and exposure patterns. These NHANES data can be used to stablish a nationally representative baseline of exposures to OPFRs and when combined with future 2-year survey data, to evaluate exposure trends.

Metabolites of Organophosphate Esters in Urine from the United States: Concentrations, Temporal Variability, and Exposure Assessment.

Urinary Metabolites of Organophosphate Esters and Implications for Exposure Pathways in Adolescents from Eastern China.

Organophosphate Ester Flame Retardants and Plasticizers in a Chinese Population: Significance of Hydroxylated Metabolites and Implication for Human Exposure.

Urinary Metabolites of Organophosphate Esters: Concentrations and Age Trends in Australian Children.

Organophosphate esters in a cohort of pregnant women: Variability and predictors of exposure

Investigation of Urinary Metabolites of Organophosphate Esters in Hanoi, Vietnam: Assessment Exposure and Estimated Daily Intake

An overview of organophosphate esters and their metabolites in humans: Analytical methods, occurrence, and biomonitoring

Human internal exposure to organophosphate esters: A short review of urinary monitoring on the basis of biological metabolism research

Estimating Renal and Hepatic Clearance Rates of Organophosphate Esters in Humans: Impacts of Intrinsic Metabolism and Binding Affinity with Plasma Proteins.

A critical review of human internal exposure and the health risks of organophosphate ester flame retardants and their metabolites

Organophosphate Esters in Human Serum in Bohai Bay, North China

Temporal Variability of Organophosphate Insecticide Metabolites over One Year in Chinese Adults.

Urinary Metabolites of Organophosphate Flame Retardants in China: Health Risk from Tris(2-Chloroethyl) Phosphate (TCEP) Exposure.

Organophosphate ester and phthalate ester metabolites in urine from primiparas in Shenzhen, China: Implications for health risks

Descriptive analysis of organophosphate ester metabolites in a pan-Canadian pregnancy cohort

Organophosphate esters in indoor dust from 12 countries: Concentrations, composition profiles, and human exposure.

Organophosphate Ester Flame Retardant Concentrations and Distributions in Serum from Inhabitants of Shandong, China, and Changes Between 2011 and 2015.

Patterns of urinary organophosphate ester metabolite trajectories in children: the HOME Study

Variability and predictors of urinary organophosphate ester concentrations among school-aged children

Exposure to organophosphate flame retardant chemicals in the U.S. general population: Data from the 2013-2014 National Health and Nutrition Examination Survey

Human Exposure to Chlorinated Organophosphate Ester Flame Retardants and Plasticizers in an Industrial Area of Shenzhen, China